93214 ⎘
Derivatives of urea, i.e. compounds containing any of the groups , the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
UREA-BASED ICE RECRYSTALLIZATION INHIBITOR COMPOUNDS AND COMPOSITIONS, AND USES THEREOF FOR CRYOPRESERVATION
#2ANTIOXIDANT INFLAMMATION MODULATORS: OLEANOLIC ACID DERIVATIVES WITH AMINO AND OTHER MODIFICATIONS AT C-17
#3ANTI-INFLAMMATORY AND ANALGESIC COMPOUNDS AND USE THEREOF
#4ZWITTERIONIC COMPOUND, AND BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANATE COMPOSITION CONTAINING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, CURED PRODUCT AND METHOD FOR MANUFACTURING SAME, AND CARBONATE COMPOUND
#5COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#6NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME
#7BICYCLOPENTANE DERIVATIVES
#8POLYCYCLIC COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#9ANTIOXIDANT INFLAMMATION MODULATORS: OLEANOLIC ACID DERIVATIVES WITH AMINO AND OTHER MODIFICATIONS AT C-17
#10COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#115-HT2A RECEPTOR INHIBITOR OR INVERSE AGONIST, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#12NAMPT MODULATORS
#13CYCLOBUTYL-UREA DERIVATIVES
#14Substituted Alkynylene Compounds As Anticancer Agents
#15SPIROUREA DERIVATIVES
#16UREA COMPOUND FOR ANTAGONIZING LPA1 RECEPTOR
#17Inhibitors of alpha 2 beta 1 integrin and methods of use thereof
#18SUBSTITUTED, SATURATED AND UNSATURATED N-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
#19Substituted bicyclic compounds
#20Substituted Ureas and Methods of Making and Using Same
#21Cyclic diones as herbicidal compounds
#22HYDROXY FUNCTIONAL ALKYL POLYUREA CROSSLINKERS
#23Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
#24Inhibitors of integrin alpha 2 beta 1 and methods of use
#25Substituted alkynylene compounds as anticancer agents
#26POLYCYCLIC COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#27Fatty acid analogues and methods of use
#28Co-crystal of sorafenib derivatives and process for preparation thereof
#29Coating composition comprising a thermoset resin and a thermoplastic resin
#30Mu opioid receptor modulators
#31Development of a cofilin inhibitor for the treatment of hemorrhagic brain injury-induced neuroinflammation
#32Substituted ureas and methods of making and using same
#33Substituted bicyclic compounds
#34Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
#35Reactive antibacterial compound and preparation method thereof
#36MU OPIOID RECEPTOR MODULATORS
#37Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same
#38Substituted ureas and methods of making and using same
#39Curable gellant ink
#40Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
#41Reactive antibacterial compound and preparation method thereof
#42Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
#43Substituted bicyclic compounds
#44MU opioid receptor modulators
#45Coating composition comprising a thermoset resin and a thermoplastic resin
#46Coating composition comprising a powder dispersed in a liquid carrier
#47Carbodiimide curing for packaging coating compositions
#48Monobloc aerosol tube or can having a coating composition
#49Hydroxy functional alkyl polyurea containing compositions
#50Hydroxy functional alkyl polyurea crosslinkers
#51Ureaurethanes for rheology control
#52SHIP1 modulators and methods related thereto
#53Reactive antibacterial compound and preparation method thereof
#54(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
#55Antioxidant Inflamation modulators: oleanolic acid derivatives with amino and other modifications at C-17
#56Substituted bicyclic compounds
#57Novel Triarylethylene Compounds and Methods Using Same
#58Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#59HYDROXY FUNCTIONAL ALKYL POLYUREA
#60NCO-free compounds and usage thereof in a curable composition
#61Substituted bicyclic compounds
#62FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE
#63FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE
#64(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
#651,3-Di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient
#66SHIP1 modulators and methods related thereto
#671,4-cyclohexylamine derivatives and processes for the preparation thereof
#68Active light sensitive or radiation sensitive resin composition, active light sensitive or radiation sensitive film, mask blank provided with active light sensitive or radiation sensitive film, pattern forming method, method for manufacturing electronic device, electronic device and novel compound
#69Colour protection detergent
#70Substituted bicyclic compounds
#71Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
#72SHIP1 MODULATORS AND METHODS RELATED THERETO
#73Synthetic route to pactamycin and pactamycin analogs
#74OMEGA-3 ANALOGUES
#75Pactamycin analogs and methods of making thereof
#76(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
#77Substituted hydroxamic acids and uses thereof
#78(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS
#79Bis-urea gelators for curable ink applications
#801,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient
#81Sorafenib derivatives as sEH inhibitors
#82Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
#83PACTAMYCIN ANALOGS AND METHODS OF USE
#84N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
#85ANTAGONISTS OF THE TRPV1 RECEPTOR AND USES THEREOF
#86Histone deacetylase inhibitors and methods of use thereof
#87Heterocyclic CETP inhibitors
#88CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#89Rheological agent for radiation-curable coating compositions
#90Antioxidant inflammation modulators: oleanolic acid derivatives with amino acid and other modifications at C-17
#912-adamantylurea derivatives as selective 11β-HSD1 inhibitors
#92-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
#93N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
#94DIACYLETHYLENEDIAMINE COMPOUND
#95COMPOUNDS AND METHODS FOR TREATMENT OF INFLUENZA
#96SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF
#97Antibacterial agents
#98Histone deacetylase inhibitors and methods of use thereof
#99PREPARATION OF NOVEL 1,3-SUBSTITUTED UREAS AS INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE
#100N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin Dreceptors
#101Probes, Systems, and Methods for Drug Discovery
#102SUBSTITUTED FLUOROETHYL UREAS AS ALPHA 2 ADRENERGIC AGENTS
#103Inhibitors for the soluble epoxide hydrolase
#104Antibacterial agents
#105Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds
#106Aminoazoline and Urea Derivatives for Combating Animal Pests
#107SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES
#108Desferrioxamine conjugates, derivatives and analogues
#109High adhesive acrylate monomer and method for preparing the same
#110Heterocyclic CETP inhibitors
#111Pactamycin analogs and methods of making thereof
#112Insecticidal substituted amino heterocyclic and heteroaryl derivatives
#113Aminotetralin-derived urea modulators of vanilloid VR1 receptor
#114Certain Chemical Entities, Compositions, and Methods
#115Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
#116N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
#117Inhibitors for the soluble epoxide hydrolase
#118Imidazopyridinyl benzamide mitotic kinesin inhibitors
#119Neo-menthyl derivatives as flavor materials
#120Imidazopyridinyl benzamide mitotic kinesin inhibitors
#121CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#122Substituted cyclohexylmethyl compounds
#123MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS
#124Indane amides
#125Antibacterial agents
#1262-adamantylurea derivatives as selective 11beta-HSD1 inhibitors
#127-disubstituted aminoalkylbiphenyl antagonists of prostaglandin Dreceptors
#128Histone deacetylase inhibitors and methods of use thereof
#129Antibacterial agents
#130Glucagon Antagonists/Inverse Agonists
#131SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#132SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#133Antithrombotic diamides
#134Powder coating of polyepoxide and polyisocyanate-amine reaction product
#1351,1′-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors
#136Illudin analogs useful as anticancer agents
#137Invention Concerning Aminoadamantane Compounds
#138Antibacterial agents
#139Melanocortin-4 receptor binding compounds and methods of use thereof
#140Substituted fluoroethyl ureas as alpha 2 adrenergic agents
#141Certain chemical entities, compositions, and methods
#142C5a receptor antagonists
#143Antibacteriall heterocyclic ureas
#144Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
#145Compounds for treatment of inflammation, diabetes and related disorders
#146Substituted Hydroxyethylamines
#147Aminotetralin-derived urea modulators of vanilloid VR1 receptor
#148LOW-CURE POWDER COATINGS AND METHODS FOR USING THE SAME
#149Histone deacetylase inhibitors
#150Phenethanolamine derivatives for treatment of respiratory diseases
#151Antibacterial agents
#152Catalyst of reaction product of polyisocyanate and tertiary amino group-containing amine, alcohol or polyol
#153Imidazoyl-benzamide anti-cancer agents
#154Heterocyclic CETP inhibitors
#155Peptidomimetic ligands for cellular receptors and ion channels
#156Inhibitors for the soluble epoxide hydrolase
#157N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
#158Powder coating of amino-urea or urethane catalyst and epoxy/hydroxy and/or siloxane resin
#159Powder coating of amino-urea or urethane catalyst and epoxy and/or siloxane resin
#160Arginine mimetics as factor Xa inhibitors
#161Diarylurea derivatives and their use as chloride channel blockers
#162Antibacterial agents
#163Bis[urea-urethane] compounds
#164Trans-1,2-cyclohexane bis(urea-urethane) compounds
#165Processes for preparing bis(urea-urethane) compounds
#166ABCA-1 elevating compounds
#167Low-cure powder coatings and methods for using the same
#168Cyclohexylurea compounds
#169Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
#170Phenethanolamine derivatives for treatment of respiratory diseases
#171Glucagon antagonists/inverse agonists
#172Aminotetralin-derived urea modulators of vanilloid VR1 receptor
#1732,3-Oxidosqualene-lanosterol cyclase inhibitors
#174Inhibitors for the soluble epoxide hydrolase
#175Peptidomimetic ligands for cellular receptors and ion channels
#176Histone deacetylase inhibitors and methods of use thereof
#177Inhibitors for the soluble epoxide hydrolase
#178Histone deacetylase inhibitors and methods of use thereof